市场调查报告书
商品编码
1470837
雷射捕捉晶粒市场:按产品、技术、应用和最终用户划分 - 2024-2030 年全球预测Laser Capture Microdissection Market by Product (Consumables, Instruments, Software & Services), Technique (Immune Laser Capture, Infrared Laser Microdissection, UV Laser Microdissection), Application, End-user - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年雷射捕获晶粒市场规模为1.6594亿美元,2024年达1.7614亿美元,2030年达2.572亿美元,复合年增长率为6.46%。
雷射捕捉晶粒(LCM) 是一种准确有效的技术,用于从各种组织样本中获取特定细胞群,使研究人员能够分离分离的细胞或详细研究特定的组织学区域。 LCM 技术的不断改进,例如提高雷射精度和自动化,透过提高各个研究领域的效率和适用性,显着促进了市场成长。了解和治疗癌症等慢性疾病的需求不断增长,推动了研究和诊断中对 LCM 的需求,从而推动了市场成长。向个人化医疗的转变和对生物标记发现的重视将进一步增加对 LCM 的需求,因为它对于分析细胞层面的疾病机制至关重要。然而,需要专门的培训来操作 LCM 设备并分析所得样本,这可能会对雷射捕获晶粒的采用构成障碍。组织製备方法会影响 LCM 解剖样本的质量,限制下游分子分析的可靠性,并对市场扩张构成挑战。此外,开拓与下游分子分析平台无缝整合的全自动LCM系统将显着提高效率和准确性,创造市场成长潜力。专注于使 LCM 变得更实惠、更容易获得的研究,尤其是在新兴市场,可能会在未来几年推动更广泛的采用并刺激市场扩张。
主要市场统计 | |
---|---|
基准年[2023] | 16594万美元 |
预测年份 [2024] | 17614万美元 |
预测年份 [2030] | 2.572 亿美元 |
复合年增长率(%) | 6.46% |
产品越来越多地采用雷射捕获晶粒仪器,因为它们能够高精度地分离特定细胞以进行详细的分子分析
耗材是 LCM 流程的重要组成部分,可确保从样本采集到下游分析流程都能维持样本的完整性和品质。专为 LCM 应用设计的检测套件、试剂和介质可提供成功晶粒所需的精确度。这些耗材确保分离细胞的生化特性得以维持,以进行进一步的分子分析。 LCM 技术仪器是先进的设备,将雷射光学的精度与软体结合,以精确定位并从组织切片中分离特定的细胞群。这些设备的复杂性和功能各不相同,有些设备包括可提高准确性和效率的自动化功能。区分这些设备的主要因素包括所使用的雷射类型、控制机构的精度、自动化程度以及与下游分析工具的整合。软体和服务是补充 LCM 技术物理方面的关键组件。该软体解决方案旨在增强 LCM 仪器的功能,为使用者提供直觉的介面,用于设计实验、控制雷射捕获过程和分析结果资料。这些软体平台通常包括影像分析、组织图谱以及与基因组或蛋白质体分析工具的整合等功能。服务还包括培训、技术支援和维护,以帮助使用者充分发挥 LCM 技术的潜力。
应用:扩大诊断应用,直接从组织分离患病细胞,并实现疾病标记的检测和分析。
在细胞生物学中,LCM 透过允许在复杂的组织环境中精确选择单一细胞或细胞群来帮助研究细胞功能、相互作用和途径。透过 LCM,科学家分离特定的细胞类型以进行下游分析,例如 RNA、DNA 和蛋白质表现。这使得我们能够更精确地了解细胞行为、细胞层面的疾病机制以及药物对特定细胞类型的影响。 LCM 能够精确检测和分析疾病标记。这种能力在癌症诊断中很有价值,区分良性和恶性细胞并识别特定突变非常重要。 LCM 允许法医学专家从多个来源的细胞混合物中选择性地分离和分析特定个体的细胞。这种准确性提高了法医学调查中 DNA 分析的可靠性,并为解决复杂案件做出了巨大贡献。在分子生物学中,LCM 用于在分子层面上解剖复杂的组织。 LCM 能够详细研究特定细胞内的基因表现、蛋白质-蛋白质交互作用和分子途径。 LCM 在推动个人化医疗方面发挥着至关重要的作用,个人化医疗可以根据每位患者的特征量身定制治疗方法。透过从患者组织样本中分离特定细胞,LCM 能够对疾病病理学进行详细的分子分析,并帮助识别疾病感受性、预后和治疗反应的生物标记。在研究和开发中,LCM 有助于药物和治疗标靶的发现和检验。它支持对复杂组织环境中特定细胞的详细分析,有助于了解疾病机制、识别新药物标靶以及评估药物疗效和毒性。
区域洞察
在美洲地区,由于在研发方面的大量投资、强大的生物技术和医学研究框架,美国在 LCM 技术的采用和开发方面处于领先地位。美国的需求主要由其强大的学术和研究机构以及製药和生物技术行业创新的持续推动。欧洲、中东和非洲地区在 LCM 技术的采用和开发方面呈现出多样化的景象。 LCM 在欧洲的采用主要是由先进的医疗保健系统、强大的研究机构以及对癌症研究和分子诊断的坚定承诺所推动的。在医疗基础设施快速发展、研发兴趣不断增强的中东地区,人们对包括 LCM 在内的先进诊断和研究技术的兴趣也在增加。非洲地区的市场成长主要是由与专注于解决感染疾病和癌症等特定健康挑战的国际组织和资助机构的合作所推动的。在扩大研究基础设施以及增加生物技术和医疗保健的政府和私人资金的推动下,亚太地区的 LCM 市场正在快速成长。中国对 LCM 等先进技术的需求正在迅速增长,中国正在大力投资医疗改革和生物医学研究。日本和印度由于生命科学领域先进的研究环境和政府的大力支持,LCM 的采用率很高。
FPNV定位矩阵
FPNV 定位矩阵对于评估雷射捕获晶粒市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对雷射捕获晶粒市场中供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.雷射捕获晶粒市场的市场规模和预测是多少?
2.在雷射捕捉晶粒市场的预测期内,有哪些产品、细分市场、应用和领域需要考虑投资?
3.雷射捕捉晶粒市场的技术趋势和法规结构是什么?
4.雷射捕获晶粒市场主要供应商的市场占有率是多少?
5. 进入雷射捕获晶粒市场的合适型态和策略手段是什么?
[196 Pages Report] The Laser Capture Microdissection Market size was estimated at USD 165.94 million in 2023 and expected to reach USD 176.14 million in 2024, at a CAGR 6.46% to reach USD 257.20 million by 2030.
Laser Capture Microdissection (LCM) is a precise and efficient technique for obtaining specific cell populations from various tissue samples, enabling researchers to study isolated cells and specific histological regions in detail. Continuous improvements in LCM technology, such as enhanced laser precision and automation, significantly drive market growth by increasing efficiency and applicability in various research domains. The increasing need for understanding and treating chronic diseases such as cancer fuels the demand for LCM in research and diagnostics, thereby propelling market growth. The shift towards personalized medicine and the emphasis on biomarker discovery further augment the demand for LCM, as it is crucial in analyzing disease mechanisms at the cellular level. However, the requirement for specialized training to operate LCM equipment and analyze obtained samples may create barriers to the adoption of laser capture microdissection. Tissue preparation methods can impact the quality of the samples dissected via LCM, potentially limiting the reliability of downstream molecular analyses and challenging market expansion. Moreover, developing fully automated LCM systems that seamlessly integrate with downstream molecular analysis platforms could significantly enhance efficiency and accuracy, creating growth potential in the market. Research focused on making LCM more affordable and accessible, especially in emerging markets, could catalyze broader adoption and spur market expansion in upcoming years.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 165.94 million |
Estimated Year [2024] | USD 176.14 million |
Forecast Year [2030] | USD 257.20 million |
CAGR (%) | 6.46% |
Product: Increasing adoption of laser capture microdissection instruments owing to their precision in isolating specific cells for detailed molecular analysis
Consumables form an essential part of the LCM process, ensuring the integrity and quality of samples are maintained throughout the capture and downstream analysis process. Assay kits, reagents, and media explicitly designed for LCM applications offer the precision required for successful microdissection. These consumables ensure that the biochemical properties of the isolated cells are preserved for further molecular analysis. Instruments in LCM technology are sophisticated devices that combine the precision of laser optics with software to accurately target and isolate specific cell populations from a tissue section. These instruments vary in their complexity and capabilities, with some offering automated features to enhance precision and efficiency. Key factors that distinguish these instruments include the different type of laser used, the precision of the control mechanisms, the level of automation, and the integration with downstream analysis tools. Software and services are critical components that complement the physical aspects of LCM technology. Software solutions have been designed to enhance the functionality of LCM instruments, providing users with intuitive interfaces to design experiments, control the laser capture process, and analyze the data obtained. These software platforms often include features for image analysis, tissue mapping, and integration with genomic or proteomic analysis tools. Services may include training, technical support, and maintenance, ensuring that users maximize the potential of their LCM technology.
Application: Widening application in diagnostics to isolate diseased cells directly from tissues, enabling the detection and analysis of disease markers
In cell biology, LCM aids in the study of cellular functions, interactions, and pathways by allowing for the precise selection of individual cells or groups of cells from within a complex tissue environment. Through LCM, scientists isolate specific cell types for downstream analyses, such as RNA, DNA, and protein expressions. This enables a more accurate understanding of cellular behavior, disease mechanisms at the cellular level, and the drug's effect on specific cell types. LCM enables the detection and analysis of disease markers at a precise level. This capability is valuable in cancer diagnostics, where differentiating between benign and malignant cells and identifying specific mutations is critical. LCM allows forensic experts to selectively isolate and analyze cells from specific individuals in a mixture of cells from multiple sources. This precision improves the reliability of DNA profiling in forensic investigations, contributing significantly to the resolution of complex cases. In molecular biology, LCM is used to dissect the complexity of tissues at the molecular level. LCM allows detailed study of gene expression, protein-protein interactions, and molecular pathways within specific cells. LCM plays a pivotal role in advancing personalized medicine, where treatments are customized to the individual characteristics of each patient. By isolating specific cells from patients' tissue samples, LCM enables the detailed molecular analysis of disease pathology, helping identify biomarkers for disease susceptibility, prognosis, and response to treatment. In research & development, LCM is instrumental in discovering and validating pharmaceutical and therapeutic targets. It supports the detailed analysis of specific cells within a complex tissue environment, aiding in understanding disease mechanisms, identifying novel drug targets, and assessing drug efficacy and toxicity.
Regional Insights
In the Americas region, the United States leads in the adoption and development of LCM technologies, driven by substantial investments in R&D, a robust biotechnology, and medical research framework. The demand in the U.S. is primarily driven by its strong academic and research institutions, alongside the pharmaceutical and biotech industries' constant push for innovation. The EMEA region shows a diverse landscape in the adoption and development of LCM technologies. LCM adoption in Europe is primarily driven by advanced healthcare systems, robust research institutions, and a keen focus on cancer research and molecular diagnostics. The Middle East, with its rapidly developing healthcare infrastructure and rising focus on research and development, shows a growing interest in advanced diagnostic and research technologies, including LCM. Market growth in Africa's region is primarily driven by collaborations with international institutions and funding bodies focused on addressing specific health challenges, including infectious diseases and cancer. The Asia Pacific region is witnessing a rapid growth in the LCM market, propelled by expanding research infrastructure and increasing government and private funding in biotechnology and healthcare. China, with its significant investments in healthcare reforms and biomedical research, exhibits a burgeoning demand for advanced technologies such as LCM. Japan and India shows a high adoption rate of LCM driven by its advanced research landscape in life sciences and strong governmental support.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Laser Capture Microdissection Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Laser Capture Microdissection Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Laser Capture Microdissection Market, highlighting leading vendors and their innovative profiles. These include 3DHISTECH Ltd., Agilent Technologies, Inc., AnaPath Services GmbH, Bio-Rad Laboratories, Inc., CaresBio Laboratory, Carl Zeiss AG, Crown Bioscience, Danaher Corporation, DeNova Sciences, DSS Imagetech Pvt. Ltd., Epistem Ltd., F. Hoffmann-La Roche AG, GE HealthCare, Gnome Diagnostics, LLC, HUBNER Group, Molecular Machines & Industries GmbH, Ocimum Biosolutions, Standard BioTools Inc., Thermo Fisher Scientific Inc., and VitroVivo Biotech LLC.
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Laser Capture Microdissection Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Laser Capture Microdissection Market?
3. What are the technology trends and regulatory frameworks in the Laser Capture Microdissection Market?
4. What is the market share of the leading vendors in the Laser Capture Microdissection Market?
5. Which modes and strategic moves are suitable for entering the Laser Capture Microdissection Market?